The Negative Side Effects of Semaglutide: What the Evidence Actually Shows

The biggest misconception: that these side effects mean treatment has gone wrong

A question our prescribers hear regularly is whether nausea or loose stools in the first fortnight signal something serious. They almost never do. The gastrointestinal effects of semaglutide are a direct consequence of how the medicine works: it slows gastric emptying and signals fullness through GLP-1 receptors, and the gut takes time to adapt. Starting at a low dose and titrating gradually is the prescriber's main tool for keeping that adjustment manageable. Letting that misconception go gently is worthwhile, because anxiety about early tolerability is one of the commonest reasons people stop treatment before it has a chance to work.

The negative side effects of semaglutide that most people actually experience are nausea (the most frequently reported), vomiting, diarrhoea, constipation, burping, indigestion and reflux, fatigue, headache, and dizziness. Injection-site redness or itching is also possible. None of these is pleasant, but clinical trial data and the STEP 1 programme (which enrolled nearly 2,000 adults over 68 weeks) showed that most participants tolerated treatment well enough to continue. You can read the trial data in detail via the STEP 1 paper in the New England Journal of Medicine. Eating smaller portions, avoiding very fatty meals, and staying well hydrated all help in the early weeks; your prescriber can advise on timing if nausea is a problem. The side effects of Wegovy across the titration schedule are worth reading about before you start, so you know what to expect at each stage.

Side effects that are uncommon but serious, and what to do

Rarer reactions need a different response. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but potentially serious effect of GLP-1 medicines including semaglutide. The symptom to recognise is severe, persistent pain in the abdomen that may radiate to the back, with or without vomiting. This is not the ordinary nausea of early treatment, it is intense and does not settle quickly. If you experience it, stop the injection and get urgent medical attention.

Other effects that warrant prompt clinical advice rather than waiting: signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, a rapidly spreading rash), gallbladder symptoms such as sudden upper-right abdominal pain or yellowing of the skin, and symptoms of dehydration from prolonged vomiting or diarrhoea, confusion, little or no urine, or a very rapid heartbeat. Semaglutide is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive; it is not licensed for anyone under 18. These are not small-print caveats; they are central to the prescriber assessment at consultation. For a fuller account of serious and uncommon reactions, the serious side effects of semaglutide page covers them in more detail.

When to get medical help, and how to report a suspected side effect

Some symptoms need a 999 call or an emergency department visit: signs of anaphylaxis, chest pain alongside breathlessness, or any neurological change. Others call for the same-day GP or pharmacist contact rather than waiting for your next scheduled review: persistent vomiting lasting more than a day or two, symptoms of dehydration, new or worsening low mood, or thoughts of self-harm. Do not sit on these.

If you experience something you believe may be a side effect, you can report it directly through the MHRA Yellow Card scheme, the scheme is open to patients, carers and healthcare professionals alike, and your report genuinely contributes to ongoing safety monitoring of these medicines. Suspected counterfeit products can also be flagged there. Concerns that arise between clinical reviews can be raised with the prescribing service, our aftercare team is available seven days a week; you can reach us at our contact page. For a broader overview of what coming off treatment involves, including any effects when stopping, stopping Wegovy and what to expect is a useful reference.

How a prescriber-led service manages tolerability over time

Semaglutide tolerability is not a one-time assessment. Dose increases (from 0.25mg through to the 2.4mg maintenance dose, and now up to 7.2mg) each carry a renewed adjustment period, and semaglutide side effects that felt settled at a lower dose can briefly reappear. A clinician review before each dose change is the safeguard that catches this early. That is why starting with a proper clinical consultation matters, and why every repeat through nume involves a fresh prescriber review rather than automatic re-supply.

People sometimes ask whether the negative side effects of Wegovy are worse than for other weight-loss medicines. The evidence does not support a simple answer; tolerability is individual and context-dependent. What is clear from the data is that most people who experience GI effects find them manageable with dose pacing and dietary adjustments, and that the minority who experience serious effects need clear, accessible advice about what to do. Our clinical team builds that conversation into every consultation rather than treating it as optional reading. If you want to explore whether semaglutide is right for you, our prescribers discuss suitability, your medical history, and exactly what each side effect of semaglutide looks like in practice as part of the free consultation; you can start that consultation here. For a complete picture before you begin, our page on side effects from semaglutide across the full course of treatment is a helpful read alongside your prescriber's guidance.